IvermectinSoolantra
Treatment of scabies when prior topical treatment has failed or is contra-indicated, and treatment of crusted scabies in conjunction with topical therapy.
Decisions on record
- Meeting Nov 2021 Recommended Scabies (sarcoptic/typical) no PSD
- Meeting Mar 2014 Recommended Stromectol® Merck Sharp & Dohme (Australia) Pty Ltd Scabies To request Authority Required (STREAMLINED) General Schedule listing for the treatment of scabies where prior topical treatment has failed or is contra-indicated and for crusted scabies in conjunction with topical therapy. For the indicatio
- Meeting Jul 2013 Recommended Round worm infestation no PSD
Access path
- TGA registered · Soolantra
TGA label narrower than the PBS population
- Mar 2014Recommended · restricted
vs placebo for crusted scabies; benzyl benzoate for typical…
- PBS listing · Authority Required
Cost-effectiveness
Cost-consequence analysis presented; cost per cure calculated but not expressed as a traditional ICER ($/QALY or $/LY). Economic analysis focused on cost per cure rather than cost-effectiveness ratio.
Decision context
PopulationAdults and children (excluding those aged less than 5 years and/or weighing less than 15kg) with typical scabies after failure of both permethrin and benzyl benzoate, or with crusted scabies in conjunction with topical therapy.
Submission history
| Decided | Outcome | Comparator | ICER | Evidence |
|---|---|---|---|---|
| Mar 2014 | Recommended · restricted | placebo for crusted scabies; benzyl benzoate for typical scabies after failure of topical treatment | — | RCT · Clinical cure |
Similar precedents
Regulatory · TGA
Label narrower than PBS population — PBAC restricts to age ≥5 years and weight ≥15kg; requires failure of both permethrin and benzyl benzoate for typical scabies.
Listed in law
PBS listings commencing 1 Apr 2022 were made by these 5 determinations under the National Health Act 1953. A determination covers every listing that commenced that day, so this is the legal instrument in force for the date — not a document naming this medicine. Open it and check.
| Determination | Made | Status | |
|---|---|---|---|
| F2022L00450 | 29 Mar 2022 | Repealed | PDF ↗ |
| F2022L00450 | 29 Mar 2022 | Repealed | PDF ↗ |
| PB 22 of 2022 | 29 Mar 2022 | In force | PDF ↗ |
| PB 23 of 2022 | 29 Mar 2022 | Repealed | PDF ↗ |
| PB 23 of 2022 | 29 Mar 2022 | Repealed | PDF ↗ |